Histone Deacetylase Inhibitors: Emerging Markets

Published - Feb 2014| Code - PHM163A| Publisher - BCC Publishing

Report Highlights

The global histone deacetylase inhibitor (HDI) market reached $153 million in 2011 and $223.2 million in 2012. This market is expected to be valued at $361.8 million in 2013 and $954.3 million by 2018, a compound annual growth rate (CAGR) of 21.4%.

Report Includes

  • An overview of the global market for histone deacetylase inhibitors.
  • Analyses of global market trends, with data from 2011 and 2012, estimates for 2013, and projections of CAGRs through 2018.
  • A breakdown of the market for histone deacetylase inhibitors not only by region, but by application as well.
  • Information pertaining to the manufacturing of HDIs as well information on the manufacturing companies involved.
  • Profiles of leading HDI companies in the market.


BCC Research carried out the market assessment of the present niche market for histone deacetylase inhibitors, the geographic breakdown of sales data, current and prospective applications, regulatory aspects, market projection, advances and restraints, patent analysis, clinical developments, market leaders and market share for histone deacetylase inhibitors.

The sales data for the global markets is authenticated for the present and anticipated values through statistical analysis. Correspondingly, regional data was measured for respective regions. The product and candidate information, technologies and platforms are based on their prospective application and practicability.

Analyst Credentials

Shalini Shahani Dewan focuses on pharmaceuticals and biotechnology and has been a BCC Research contributor since 2002 as both an analyst and project manager. She has explored a wide range of topics and companies, including working for Johnson & Johnson doing market surveillance. She has an undergraduate degree in pharmacy and master's degree in medicinal chemistry. She resides in the Bay Area.

Latest reports include:

Table of Contents & Pricing

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Note: Reports are discounted or included with certain Memberships. See Membership Options.
Title/Chapter Name Pages Price Member Price
Full Report: Histone Deacetylase Inhibitors: Emerging Markets 153 $2,750 Free
Chapter- 1: INTRODUCTION4Free
Chapter- 2: EXECUTIVE SUMMARY3$250Free
Chapter- 3: OVERVIEW30$539Free
Chapter- 4: REGULATORY ASPECTS7$126Free
Chapter- 5: NEW DEVELOPMENTS15$270Free
Chapter- 7: MARKET BY APPLICATION12$216Free
Chapter- 8: PATENT ANALYSIS18$324Free
Chapter- 9: CURRENT SITUATION5$90Free
Chapter- 10: COMPANY PROFILES41$737Free
Chapter- 11: ABBREVIATIONS3$54Free
Share This Report